Friday, November 22, 2024
11/22/2024
DESCRIPTION (provided by applicant): T cell malignancy is a complex process involved in deregulation of cell proliferation and/or apoptosis, including down-regulation of cyclin-dependent kinase inhibitor p27 KIP1. We have identified a T-cell specific protein p80 pro-IL-16, the precursor of Interleukin-16 (IL-16), as a critical negative regulator for p27 KIP1. P80 pro-IL-16 is a nuclear protein highly expressed in resting T cells but rapidly diminished upon T cell activation. The p80 pro-IL-16 gene is located to Ch15q26.3, a site frequently deleted in human T cell malignancies. We have shown that p80 pro-IL-16 is inactivated, either by deletion or mutation in the p80 pro-IL-16 gene, in four T cell malignant cell lines examined and in human primary T cells derived from Sezary syndrome patients. Ectopic expression of p80 pro-IL-16 specifically suppresses Skp2 expression leading to accumulation of p27 KIP1 and Go/G1 cell cycle arrest. P80 pro-IL-16 contains three PDZ domains, which specifically interact the histone deacetylase 3 (HDAC3) and the transcription factor cAMP responsive element binding protein 3 (CREB3). Together, these data strongly suggest that p80 pro-IL-16 play an important role in T cell malignancy. We hypothesize that (1) p80 pro-lL-16 is an adaptor protein that functions to assembly a nuclear protein complex in repressing Skp2 gene transcription in a histone deacetylase-dependent manner and (2) the loss of P80 pro-IL-16 plays an important role in the development of T cell malignancies. Two specific aims are proposed in this application including (1) to elucidate the mechanism(s) by which p80 pro-lL-16 regulates p27 KIP1 protein expression; and (2) to investigate the role of p80 pro-lL-16 in the development of T cell malignancies. We will focus on the p80 pro-IL-16-mediated suppression of Skp2 gene transcription and the role of HDAC3/CREB3 in this action.. We will investigate whether p80 pro-IL-16-null mice are predisposed to T cell malignancies induced by the chemical carcinogen N-methyl-N-nitrosourea (MNU). This study will lead to a considerable insight of the role of p80 pro-IL-16 in the T cell cycle regulation and T cell malignancy and help to identify diagnostic and/or therapeutical targets for human T cell malignancies.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
